$2.15
-0.07 (-3.15%)
Open$2.23
Previous Close$2.22
Day High$2.26
Day Low$2.12
52W High$3.27
52W Low$0.97
Volume—
Avg Volume117.1K
Market Cap17.10M
P/E Ratio—
EPS$-7.37
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+934.4% upside
Current
$2.15
$2.15
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.24M | 4.81M | 4.77M |
| Net Income | -916,995,707 | 633.7K | 796.1K |
| Profit Margin | -73,682.7% | 13.2% | 16.7% |
| EBITDA | -919,737,765 | 1.15M | 1.15M |
| Free Cash Flow | — | 870.8K | 772.5K |
| Rev Growth | — | +22.7% | +21.0% |
| Debt/Equity | — | 0.81 | 0.64 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |